Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments: 2012-2019

Historic Change in Acquisitions & Divestments for Cumberland Pharmaceuticals (CPIX) over the last 8 years, with Dec 2019 value amounting to $20.1 million.

  • Cumberland Pharmaceuticals' Change in Acquisitions & Divestments fell 110.53% to -$460,888 in Q4 2020 from the same period last year, while for Dec 2020 it was $11.5 million, marking a year-over-year decrease of 42.69%. This contributed to the annual value of $20.1 million for FY2019, which is 24.44% up from last year.
  • According to the latest figures from FY2019, Cumberland Pharmaceuticals' Change in Acquisitions & Divestments is $20.1 million, which was up 24.44% from $16.1 million recorded in FY2018.
  • Cumberland Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $20.1 million for FY2019, and its period low was $4.5 million during FY2016.
  • For the 3-year period, Cumberland Pharmaceuticals' Change in Acquisitions & Divestments averaged around $16.5 million, with its median value being $16.1 million (2018).
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Change in Acquisitions & Divestments plummeted by 43.05% in 2016, and later soared by 198.08% in 2017.
  • Over the past 5 years, Cumberland Pharmaceuticals' Change in Acquisitions & Divestments (Yearly) stood at $7.9 million in 2015, then crashed by 43.05% to $4.5 million in 2016, then surged by 198.08% to $13.4 million in 2017, then climbed by 20.49% to $16.1 million in 2018, then climbed by 24.44% to $20.1 million in 2019.